Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Marshall › NPI 1922532555
Physician

East Texas Border Health Clinic

East Texas Border Health Clinic was paid $2.59M by Medicaid between Mar 2020 and Dec 2024, across 72 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 71% of everything it billed.

33Billing provider infoEAST TEXAS BORDER HEALTH CLINIC
MARSHALL, TX 75670
33aNPI1922532555assigned 04/20/2017
33bProvider typePediatrics Physician
28Total paid$2.59M
24GClaims63,806
24DCodes billed72
24AFirst – last monthMar 2020 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in Texas

Rank by total paid#184 of 1,136
Median peer was paid$329K
This provider vs. median7.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ROADCAP, CARLA controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20205,246$131K
202121,729$730K
202215,966$726K
202312,366$562K
2024incomplete8,499$443K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 71% 15,988 13,343 $1.85M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 12% 7,645 6,913 $311K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 3.6% 1,337 1,251 $94K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 3.1% 1,159 1,105 $81K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 2.9% 1,039 1,010 $75K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2.5% 1,928 1,840 $65K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1.2% 638 579 $32K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1.2% 426 417 $30K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,188 2,087 $18K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 357 336 $8K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 1,721 1,568 $8K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 695 334 $6K
60 more codes
97803 <1% 414 $4K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 389 $4K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 114 $2K
99203 Doctor's office visit, new patient (routine) <1% 30 $1K
97802 <1% 194 $980.69
81025 <1% 220 $520.56
92552 <1% 874 $348.31
99000 <1% 28 $237.60
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 27 $184.66
96160 <1% 526 $156.99
87807 <1% 12 $110.00
81003 <1% 103 $86.94
90460 Immunization administration through 18 years of age via any route, first or only component <1% 3,056 $86.62
2015F <1% 1,116 $40.00
90686 <1% 1,121 $19.26
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 124 $5.76
90461 <1% 1,433 $1.60
90620 <1% 238 $1.37
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 246 $0.37
90472 Immunization administration, each additional vaccine (list separately) <1% 75 $0.03
90715 <1% 114 $0.02
G8431 Screening for depression is documented as being positive and a follow-up plan is documented <1% 126 $0.02
96161 <1% 30 $0.02
90670 0% 467 $0.00
3028F 0% 944 $0.00
99173 0% 2,818 $0.00
4120F 0% 2,479 $0.00
4124F 0% 611 $0.00
1033F 0% 697 $0.00
4025F 0% 133 $0.00
1039F 0% 1,432 $0.00
90633 0% 133 $0.00
3210F 0% 130 $0.00
4325F 0% 35 $0.00
90700 0% 15 $0.00
90734 0% 455 $0.00
90710 0% 160 $0.00
90671 0% 18 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 0% 36 $0.00
5250F 0% 68 $0.00
2016F 0% 1,404 $0.00
96127 0% 464 $0.00
2010F 0% 940 $0.00
1038F 0% 535 $0.00
1031F 0% 461 $0.00
90680 0% 68 $0.00
90651 0% 517 $0.00
90723 0% 76 $0.00
36416 0% 156 $0.00
2030F 0% 116 $0.00
3351F 0% 81 $0.00
90647 0% 152 $0.00
4140F 0% 239 $0.00
4056F 0% 27 $0.00
2000F 0% 745 $0.00
3008F 0% 1,307 $0.00
1005F 0% 89 $0.00
2001F 0% 43 $0.00
4293F 0% 12 $0.00
90697 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialROADCAP, CARLA (CEO)
Same official

Other billing entities under ROADCAP, CARLA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.